ArticlePathogens (Basel, Switzerland)2023

Newly Designed Poxviral Promoters to Improve Immunogenicity and Efficacy of MVA-NP Candidate Vaccines against Lethal Influenza Virus Infection in Mice.

Martin C Langenmayer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.